Analyst firms · Needham · XRAY
Needham XRAY price target and rating history
DENTSPLY SIRONA Inc. (XRAY) · Health Care
Needham rates DENTSPLY SIRONA Inc. (XRAY) Hold with a $29 price target, as of its latest action on Mar 13, 2025. It has published 4 rating actions on XRAY since November 2023, including 0 upgrades and 1 downgrade. Across 4 firms with a XRAY price target in the last 12 months, the median target is $12.
- Current rating
- Hold
- Price target
- $29
- Median target, all firms
- $12
- Actions on XRAY
- 4
Needham price target on XRAY
Every Needham rating on XRAY
- Mar 13, 2025DowngradeNeedham downgrades to Hold from Buy
- Oct 25, 2024
- Aug 20, 2024
- Nov 16, 2023
How other firms rate XRAY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $12 | Jul 9, 2026 |
| Citigroup | Sell | $10 | Apr 15, 2026 |
| BofA Securities | Buy | $17 | Feb 19, 2026 |
| Barclays | Underweight | $12 | Dec 9, 2025 |
Questions about Needham and XRAY
- What is Needham's price target for XRAY?
- Needham's latest stated price target for DENTSPLY SIRONA Inc. (XRAY) is $29, from its action on Oct 25, 2024.
- What is Needham's rating on XRAY?
- Needham rates XRAY Hold, a neutral rating, as of Mar 13, 2025.
- When did Needham last change its view on XRAY?
- On Mar 13, 2025, Needham downgrades to Hold from Buy.
- How does Needham's XRAY target compare with other analysts?
- Across 4 firms with a XRAY price target in the last 12 months, the median target is $12.
More XRAY rating histories
All Needham ratingsXRAY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.